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Resumo  
  
 A sepsis representa a resposta inflamatória sistémica do hospedeiro a umainfecção, 
(Iskanderet al., 2013) e é a 15ª causa mais significativa de morbidade e mortalidade em todo o 
mundo. A sepsis provoca 20 a 30 milhões de casos anuais no mundo inteiro causando uma 
morte a cada 3-4 segundos (WSD et al., 2013). Os pacientes com sepsis requerem custos 
substanciais de cuidados de saúde durante a sua hospitalização. Para além disso, os 
sobreviventes incorrem em custos adicionais devido ao aumento dos requisitos de cuidados de 
saúde nos anos que se seguem ao episódio da sepsis (Iskanderet al., 2013) 
 A sepsis é um processo complexo que pode ser iniciado por uma ampla gama de 
infeções, bacterianas, virais ou fúngicas, numa ampla gama de locais corporais. Muitos são os 
fatores de risco que despoletam um choque séptico ou o desenvolvimento da sepsis severa. 
Estes incluem, idade (75-85 anos), etnia e sexo (Alexander Melamed et al., 2009), bem como 
comorbidades como o cancro (linfomas ou leucemias), ou outras doenças imunossupressivas 
como HIV ou diabetes(Martin GS et al., 2006). As infeções nosocomiais, resultantes da 
exposição ao ambiente hospitalar, também são uma causa importante de sepsis (Farinas 
Alvarez et al., 2001). 
 Na fisiopatologia desta doença heterogénea, uma resposta inflamatória intensa é 
desencadeada, e seguida por uma cascata de eventos secundários, incluindo disfunção 
endotelial, coagulopatia, apoptose celular e imunossupressão (Stearns-Kurosawaet al., 2011). 
Uma infeção localizada torna-se assim uma síndrome sistémica, mediada por fatores solúveis 
como citoquinas e células imunes circulantes, como neutrófilos e leucócitos (Stearns-
Kurosawaet al., 2011). Estes eventos contribuem para a disfunção progressiva dos órgãos e, 
posteriormente, a morte. 
 O diagnóstico precoce da sepsis pode ser desafiador devido à existência de outras 
doenças com apresentações similares. Os “imitadores” de sepsis incluem insuficiência 
cardíaca, insuficiência renal, pancreatite, anafilaxia, embolia pulmonar, isquemia intestinal, 
cetoacidose diabética e vasculite, entre muitos outros. Os marcadores de proteínas da sepsis, 
incluindo a procalcitonina e a proteína C-reativa, não são confiáveis (José Raimundo Araújo  
prognóstico. 
 Este projeto visou estudar esta doença complexa de uma forma inovadora. Com 
colaboração com um grupo de investigadores no Canadá, criou-se pela primeira vez uma 
coorte de pacientes sépticos (n=68) e pacientes com terapia intensiva não-séptica (n=66). Um 
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estudo chamado EPSIS (EpigeneticProfiling in Severe Sepsis) visou compreender a 
importância da regulação epigenética na patogénese, progressão, resposta ao tratamento e 
resultados de pacientes sépticos críticos.  
 
 Esta tese focou-se na hipótese que pacientes com e sem sepsis apresentavam 
diferentes padrões de metilação de DNA nos genes implicados na patogénese de sepsis. Como 
primeiro objetivo e fase neste projeto, identificou-se genes-chave na regulação epigenética na 
sepsis. Identificou-se genes que são diferencialmente regulados na sepsis, e que se 
correlacionam com diferentes vias e consequências metabólicas importantes, como a 
coagulopatia, disfunção endotelial, imunossupressão eimunoactivação e apoptose. Assim, 
após esta revisão bibliográfica extensa criou-se um cluster inicial de 128 genes.  
 De seguida, com os dados de metilação provenientes do coorteda EPSIS, analisou-se 
as diferenças de metilação de DNA entre as várias sondas dos 128 genes, potenciado, desta 
forma, a criação do segundo cluster de genes que se mostraram significativos na distinção de 
um paciente com sem sepsis e sem sepsis.  
 Na terceira fase, e como o nosso foco assentava na análise desta doença de uma 
maneira robusta, analisámos trêsconjunto de dados, provenientes do GeoDatasets, que 
avaliaram expressão de genes em pacientes com e sem sepsis. Assim, apesar de não podermos 
fazer uma correlação direta entre os nossos dados de metilação e os dados da transcriptómica, 
conseguimos entender quais os genes que estão diferencialmente regulados na patogénese 
desta doença.  
 Com as análises de metilação e de transcrição criou-se, pela primeira vez, um grupo 
de 10 genes que se mostraram estar diferencialmente metilados e expressos na sepsis. Entre 
esses incluem-se HLA-A, HLA-C, HLA-DOB, HLA-DQB1, FADD, APOL3, ITGB2, 
NLRP12, VARS2 e C3AR1. Este grupo de genes desempenha diferentes funções como 
inflamação, apoptose, imunidade inata e adaptativa. As análises mostraram que metade destes 
genes apresentaram um elevado grau de metilação, nomeadamente HLA-DOB, APOL3, 
FADD, NLRP12 e VARS2, enquanto os outros cinco (HLA-A, HLA-C, HLA-DQB1, 
C3AR1, ITGB2) se encontravam hipometilados. Analisando as diferenças ao nível de 
expressão genica a maioria destes genes encontravam-se subregulados.  
 A última fase deste projeto focou-se na correlação de parâmetros clínicos relevantes 
com a metilação dos 10 genes que anteriormente se revelaram significativos. Diferentes 
parâmetros foram analisados para a coortede pacientes, incluindoos dias de permanência da 
unidade de cuidados intensivos, os dias de sobrevivência, o tipo de cultura bacteriana (gram-
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positiva ou gram-negativa); administração de vasopressores, esteróides, ventilação mecânica; 
e presença de doenças crónicas incluindoinsuficiência cardíaca e doença cardíaca isquémica. 
Em cada um destes parâmetros analisou-se varias sondas de CpG que apresentaram 
significância estatística e pudemos estabelecer uma relação entre metilação destes genes eo 
parâmetro clínico. 
 
 Este projeto centrou-se no estudo da sepsis, uma doença altamente complexa, 
heterogénea, e frequentementefatal. Nós reunimos, para a primeira vez, perfis de metilação de 
DNA de 66pacientes sépticos e 68pacientes com terapia intensiva não-séptica e compáramos 
esses dados com informações de transcriptómica de 3coortes diferentes de pacientes com 
sepsis. Adotamos uma abordagem de bioinformática para identificar e estabelecer assinaturas 
de metilação de DNA da sepsis em um conjunto focado de genes relacionados a sepsis. Dez 
desses genes, incluindo HLA-A, ITGB2, FADD, e APOL3, mostraram mudanças 
significantes de metilação e transcrição, sugerindo regulação epigenética. Além disso, 
identificamos correlações entre várias sondas CpG e parâmetros clínicos, incluindo infecção 
gram-positiva versus gram-negativa, sobrevivência global, e necessidade de vasopressores. 
 
 
 
Palavras-chave:  
Epigenética, Sepsis, Metilação de DNA, Biomarcadores 
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Abstract  
  
 Sepsis is a life-threatening complication of infection. Typically, a localized infection 
triggers a systemic inflammatory cascade resulting in widespread organ damage, organ 
failure, and often death. Of the 31.5 million cases of sepsis worldwide annually, it is 
estimated that there are 5.3 million deaths (Fleischmann et al., 2016). The pathophysiology of 
sepsis involves widespread reprogramming of gene expression. Bioinformatic approaches 
have revealed multiple gene pathways that are activated or inhibited in sepsis (DC Angus and 
Tom Van der Poll et al., 2013). Epigenetic mechanisms, including histone modifications, 
DNA methylation, and non-coding RNAs (such as microRNAs, siRNAs, andribosomal 
RNAs) are master regulators of gene expression in both normal and pathological states. 
Although there is limited data on epigenetic regulation of sepsis, localized epigenetic changes 
have been identified in individual genes.However no genome-wide data has yet been 
published. In this studywe define a number of sepsis-related DNA methylation changes in 
sepsis-associated genes. We correlate these changes with gene expression and with clinically-
relevant outcomes. Finally, we will investigate the mechanisms by which DNA methylation 
regulates individual gene expression in sepsis. 
 
Keywords: 
Epigenetic, Sepsis, DNA Methylation, Biomarker 
 
 A sepsis é uma complicação potencialmente fatal derivada de uma infecção. 
Normalmente, uma infecção localizada desencadeia uma cascata inflamatória sistémica, 
resultando em danos generalizados nos órgãos, falência de órgãos e, muitas vezes, a morte. 
Dos 31,5 milhões de casos de sepsis reportados em todo o mundo anualmente, estima-se que 
haja cerca de 5,3 milhões de mortes (Fleischmann et al., 2016). A fisiopatologia da sepsis 
envolve a reprogramação generalizada da expressão génica. As abordagens bioinformáticas 
revelaram múltiplas vias genéticas que são ativadas ou inibidas na sepsis (DC Angus e Tom 
Van der Poll et al., 2013). Os mecanismos epigenéticos, incluindo modificações nas histonas, 
metilação do DNA e RNAs não codificante (como microRNAs, siRNAs ou RNAs 
ribossómicos) são os principais reguladores da expressão genica, em estados normais e 
patológicos. Embora haja dados limitados sobre a regulação epigenética da sepsis, ainda não 
foram publicados dados genome-wide. Neste projecto, definiremos as mudanças de metilação 
do DNA que caracterizam a sepsis em genes associados a patogénese da doença. Iremos 
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correlacionar essas mudanças com a expressão génica e com parâmetros clínicos relevantes. 
Finalmente, investigaremos os mecanismos pelos quais a metilação do DNA está a regular 
individualmente cada gene envolvido na sepsis.  
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1. Introduction 
 
1.1- Sepsis 
 Sepsis represents the host´s systemic inflammatory response to a severe infection 
(Iskanderet al., 2013). It is the 15th most significant cause of morbidity and mortality 
worldwide. In 2016 it was estimated there were 31.5 million cases of sepsis and 19.4 million 
cases of severe sepsis worldwide, with over 5 million deaths (Fleischamann et al., 2016). 
Sepsis patients incur substantial health care costs during hospitalization and survivors incurs 
additional costs due to increased health care requirements in the years following their sepsis 
episode (Iskander et al., 2013). Although sepsis episodes are short, lasting only days to weeks 
(as opposed to cancer or other chronic diseases), the associated costs are very high accounting 
for more than 5% of total US hospital costs ((KN Iskanderet al., 2013, Torio CM et al., 2011). 
Mortality from severe sepsis is also extremely high, with over 40% of patients admitted to the 
ICU ultimately dying, despite receiving all necessary care.  
 
1.2- Infection and Immunity 
 Sepsis is a complex process that can be initiated by a wide range of infections, 
including bacterial, viral and fungal, in almost any body site including the lungs, kidney, 
abdomen, brain, soft tissues, and blood stream. Risk factors for sepsis include age, ethnicity 
and sex (Alexander Melamed et al., 2009) as well as comorbidities such as cancer, HIV, and 
diabetes (Martin GS et al., 2006; Kang et al., 2011).  Nosocomial infections, resulting from 
exposure to the hospital environment, are also an important cause of sepsis (Farinas Alvarez 
et al., 2001).  In US studies the groups with the worst outcomes from sepsis are African-
Americans, elderly males between age 75 and 84, and those with nosocomial infections 
(Alexander Melamed et al., 2009).  
1.2.1- Infection 
 
 The immune system consists of a network of organs, cells and molecules thataims to 
maintain homeostasis of the body during an infection (Cruvinelet al., 2010). The non-specific 
response is immediate and maximum, independent of the antigen and does not result in 
immunological memory. It is represented by physical, chemical and biological barriers and 
 
 
 
2 
can recognize structures shared by microorganisms, named pathogen-associated molecular 
patterns (PAMPs). Among them are nucleic acids (e.g. single stranded RNAor double 
stranded RNA present in viruses), proteins, cell wall lipids (LPS in gram negative bacteria) 
and carbohydrates (e.g. beta-glucan, present in fungi). Innate immune cells, namely 
macrophages, defend against pathogensby means of surface receptors that recognize and bind 
to microbial components (https://www.ncbi.nlm.nih.gov/books/NBK27090/). The receptors 
are known as pattern recognition receptors (PRRs), among which the family of toll-like 
receptors (TLRs) is the most studied. TLRs play a central role in binding to pathogens and 
triggering the initiation of aninflammatory response (Takeda et al., 2005). TLR-4, for 
examplebinds to the gram-negative cell wall component LPS, while TLR-2 recognizes 
specific structures on the membrane of gram-positive bacteria (Cohen et al., 2002; Opal et al., 
2002).  
 
1.2.2- Innate Immunity 
 
 This first line of defence involves physicial barriers, including the epitheliumand 
endothelium at entry points such as the skin,respiratory and gastrointestinal systems. These 
are also the sites where the main effector cells of innate immunity act, including 
macrophages, neutrophils, dendritic cells and Natural Killer (NK) cells. Phagocytosis the 
release of inflammatory mediators, and activation of the complement system constitute the 
main defence mechanisms of innate immunity. The innate immune response also triggers the 
release of cytokines and chemokines, secreted proteins involved in the immune response and 
management of immune cell trafficking. These proteins have growth, differentiation and 
activation functions (Borishet. al., 2003) and their production is induced by an immune insult. 
Cytokines may have both pro and anti-inflammatory potential; their ultimateactivity 
dependingon the immune cells present and their state of responsiveness to the cytokine (Mark 
D. Turner et. al., 2014).  Early recognition of bacterial substances is important for the immune 
response and for overall survival. The role of the innate immune system is to detect 
microbialproducts in the tissues and to trigger an effector function to the site of infection 
(Martin et al., 2000).  
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1.2.3- Adaptive Immunity 
 
  Unlike theinnate response, the adaptive immune response depends on the activation 
of specialized cells, lymphocytes and soluble molecules. Itis more targeted and specialized to 
fight an infection. The adaptive immune response is characterized by specificity and diversity 
of pathogen recognition, response expertise,  tolerance to the body's own components, and the 
creation of immunological memory. In addition to lymphocytes, antigen presenting cells 
(APCs) play a key role in the activation of the adaptive response by presenting antigens to T 
lymphocytes. 
 
 This secondphase of the immune response begins when a pathogen is ingested by 
an immature dendritic cell in the infected tissue. These immune cells are derived from the 
same bone marrow precursors as macrophages.After ingestion of a potential pathogen, the 
dendritic cell migrates to the lymph nodes where it “presents” the microbial antigens to 
circulating lymphocytes. Lymphocytes are white blood cells that provide the effector function 
of the adaptive immune system. They are divided into two classes - B cells, that mediate 
antibody responses, and T cells, that provide cell-mediated immune responses. 
Illustration 1 provides a brief overview of immune system activation in response to a viral 
infection: 
 
 
 
 
 
 
  
 
 
 
 
 
 
Illustration  1: Adaptive immunity: the two classes of 
lymphocytes. B cells secrete antibodies that neutralize the 
virus. And T cells that act primarily on inducing the death of 
cells that were previously infected by a virus.(Adapted from 
Alberts B et al., 2002) 
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1.3- Pathophysiology of Sepsis 
1.3.1- Immunoactivation and Immunosuppression 
 
The pathophysiology of sepsis is complex and only partially understood. In response 
to infection, an intense inflammatory response is mounted. A set of inflammatory mediators 
are produced and released into the bloodstream, including TNF-α, IL-1, IL-6, and IL-8. 
These mediators have the capacity to bind to target cells and trigger signal transduction and 
activate secondary response pathways (Rubinstein et al., 1998).). The immune response is 
complex and includes simultaneous immune activation and immunosuppression(Hotchkiss 
et al., 2003).  
As a result of increased osmotic pressure extravascularly and increased hydrostatic 
pressure intravascularly, fluid, proteins, red blood cells and white blood cells escape from the 
intravascular space. This facilitatesthe flow of chemical mediators and inflammatory cells 
towards the stimulus but also causes tissue edema and damage (Hunter et al., 2012). Other 
secondary events in sepsis includeendothelial dysfunction, coagulopathy, and cellular 
apoptosis, all of which contribute toorgan failure (Stearns-Kurosawa et al., 2011), A localized 
infection thus becomes a systemic syndrome (Stearns-Kurosawa et al., 2011). These events 
contribute to progressive dysfunction of organs and subsequently death.   
1.3.2- Apoptosis 
 
Apoptosis, or “programmed cell death”, is also dysfunctional in sepsis. 
Widespread cell death among immune cells (dendritic cells, monocytes, macrophages and 
lymphocytes) contributes to a state of secondary immunosuppression (Hotchkiss et al., 
2003). This compromises the ability of the patient to eradicate the initial infection and 
predisposes them to secondary infections, such as nosocomial infections (Wesche et al., 
2005). 
 
1.3.3- Endothelial Integrity 
 
In normal conditions, fibrinolysis is strongly regulated and kept in balance by the 
endothelium, such that it allows blood to flow freely without systemic bleeding or clotting 
(Levi M et al., 2013). However, in an hyperinflammation situation during severe sepsis 
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drives hemostasis toward a prothrombotic and antifibrinolytic state, which can lead to 
disseminated microvascular thrombosis, organ ischemia, and MODS (Levi M et al., 2013). 
Inflammatory meditors like IL-6, vWF, protein C, plasma-free hemoglobin,  
are some of the essential mediators for the disseminated platelet, activating the coagulation 
products or activating the fibrinolytic pathway (Can Ince et al., 2016).  These mediators are 
directly correlated with coagulation and fibrinolysis. For example, protein C is one of the 
molecules produced by endothelial cells in cases of intact endothelium. These endothelial 
cells serve as a barrier between blood products and procoagulant molecules, such as heparin, 
residing in the extracellular matrix.   
Under normal conditions, large numbers of peripheral blood neutrophils, induced 
by the colony stimulating factors granulocyte colony-stimulating factor (G-CSF) and 
granulocyte macrophage colony-stimulating factor (GM-CSF), enter sites of bacterial 
infection by first adhering to activated endothelial cells and then migrating along a gradient 
of chemotactic factors. These chemotactic factors are produced at the local site of infection. 
Neutrophils use toll-like receptors (TLR-2 or TLR-4) to interact with pathogen-associated 
molecular patterns (PAMPs) on bacteria to phagocytize and eliminate the pathogens. 
However, neutrophils from septic patients have increased expression of surface integrins, 
which promote firm adhesion to endothelial cells. As a consequence, the neutrophils remain 
bound more tightly to the endothelial cells and fail to migrate appropriately into the site of 
the bacterial infection, which result in a continuous bacterial infection and an accumulation 
of neutrophils on the endothelial wall. 
This endothelial disruption comes begins briefly this way because of increased 
expression of adhesion molecules on the endothelial cells, resulting in attachment of white 
blood cells. Also become increasingly the cross talk exists between the coagulation system 
and the inflammation system in sepsis (Abraham et al., 2000).  
 Due to its importance in the pathophysiology of sepsis, endothelium function has 
been one of the routes that have been chosen to create new therapeutics, namely inducing the 
release of proinflammatory cytokines such as IL-6 (Cianferoni S et al., 2013).  
1.3.4- Coagulopathy 
 
The coagulation system, through complex interactions, also plays an important 
role in the sepsis-induced inflammatory cascade. A balance that normally exists between 
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anticoagulant mechanisms and the procoagulant response is altered in sepsis with the 
balance tipped towards coagulation. Activated protein C (APC), an endogenous vitamin K-
dependent anticoagulant, plays a major role in the down-regulation of the procoagulant arm 
and was briefly used as a treatment for sepsis although it ultimately proved ineffective 
(Robert Satran et al., 2003).  
In sepsis there is a generalized activation of the clottingcascade leading to the 
formation of clots in small vessels along with tissue hypoperfusion and a cytopathic hypoxia 
(Fink et al., 1997; Remick et al., 2007). Cytopathic hypoxia refers to conditions in which 
mitochondria have reduced ability to perform aerobic respiration and oxidative 
phosphorylation due to relative lack of oxygen. 
1.4- Epigenetics 
 
Epigenetic is the "science of change" (Bob Weinhold et al.,2006). The word 
epigenetic literally means "additional changes that occur in the genetic sequence". This term 
encompasses any process that alters gene expression without changing the DNA sequence. 
These changes are heritable and are therefore passed on to daughter cells. Many diseases 
have some level of evidence linking them with epigenetic mechanisms, including cancer of 
almost all types, cognitive and cardiorespiratory disorders, such as cardiac hypertrophy 
(Charbel Khalil et al., 2014); reproductive disorders, namely obesity and several cancers of 
the reproductive system, such as endometrial, ovarian, breast, testicular and prostate cancers 
(Crujeiras et al., 2015(, and also autoimmune diseases, including SLE (Systemic lupus 
erythematosus), autoimmune thyroid disease, inflammatory bowel disease, psoriasis (Judith 
Greer et al., 2012) and neuro-degenerative diseases, such asHuntington's disease (Luca 
Lovrečić et al., 2015,Weinhold et. al.,2006). Common epigenetic modifications include 
DNA methylation; histone modifications such as methylation, acetylation, phosphorylation 
and ubiquitination; and non-coding RNAs, including microRNAs.  
Of all the epigeneticprocesses, the best-known and most studied is DNA 
methylation. This change occurs at cytosine bases, which are converted into 5-
methylcytosine by DNA methyltransferase enzymes (DNMT). The modified cytosine 
residues are almost always associated with a guanine residue and are known as CpG sites.  
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1.4.1- DNA Methylation 
 
DNA methylation is the most studied of the epigenetic changes. It involves 
addition of a methyl group to a cytosine residue in a cytosine-guanine pair. In mammals, 
there are 3 major DNA methyl transferases: DNMT1, DNMT3a and DNMT3b. DNMT1 is a 
maintenance methyltransferase, while DNMT3a and 3b are de novo methyltransferases 
(Phillips et al.,2008). DNMT1 is the most abundant DNMT in adult cells (Robertson et 
al.,1999). It binds to hemimethylated DNA (DNA with only one strand methylated), at CpG 
sites. After DNA replication, although the parent strand remains methylated the newly 
synthesized strand is not. DNMT1 binds to these hemimethylated CpG sites and methylate 
the cytosines on the newly synthesized strand. The de novo DNA methyltransferases 
DNMT3a and DNMT3b do not require hemimethylated DNA to bind: they show an equal 
affinity for hemimethylated and non-methylated DNA (Okano et al.,1998). Both DNMT3a 
and DMNTb are essential for early development, and the loss of either is lethal. It should be 
noted that the role of these enzymes is not restricted and absolute, DNMT1 can function as a 
de novo DNMT whileoverexpression of DNMT1 leads to de novo methylation of CpG 
islands (Vertino et al.,1996).  
A new class of ezymes,ten eleven translocation (TET) enzymes oxidize 5-
methylcytosines (5mCs) and promote locus-specific reversal of DNA methylation. The TET 
family comprises three main proteins, namely, TET1, TET2, and TET3—that catalyze the 
successive oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-
formylcytosine (5fC), and 5-carboxylcytosine (5caC) (He et al., 2011). Disruption of 
epigenetic landscapes, including DNA methylation patterns, is a hallmark of different 
diseases, including cancer. When theses enzymes are muted a disruption of crucial proteins 
happens (Kasper Dindler Rasmussen et al., 2016). 
 
1.4.2- Histone Modifications 
 
Histone modifications are covalent post-translational modifications (PTM) of the 
histone proteins, which bind to DNA and give chromatin its structure. Histones can be post-
translationally modified to restructure chromatin in many ways, including by 
phosphorylation, ubiquitination, acetylation, and methylation (Kouzarides et al.,2007). 
Histone modifications can impact gene expression by altering chromatin structure or by 
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recruiting histone modifiers. Among these different modifications, histone acetylation, at the 
ε-amino group of lysine residues in H3 and H4 tails, is the one most consistently associated 
with promoting transcription (Diane Handy et al.,2011). Histone proteins form histone 
cores, consisting of 8 histone proteins, and act to package DNA, which wraps around the 
histone cores into chromosomes. With respect to histone modification, histone acetylation 
seems to be important for the regulation of proinflammatory gene expression in lung 
epithelial cells (Mélanie Anne Hamon et al.,2008). Expression of H3-acetyl, H3K4me2 and 
H3K9me2 are associated with modulation of IL-8 transcriptional activity in response to LPS 
exposure (T.Angrisano et al.,2010). In monocytes, chromatin remodelling occurs at the 
promoters of pro-inflammatory and anti-inflammatory genes after LPS stimulation, 
increasinglevels of H3K9me2 in pro-inflammatory genes like IL-6, IL-12 and TNF-α. The 
expression of H3K9me2 in monocytes increases the capacity to produce anti-inflammatory 
cytokines, such as the IL-1 receptor antagonist (IL-1RA) and IL-10 (Cavaillonet al.,2006; 
Biswas et al.,2009). 
1.4.3- Non-coding RNAs 
 
A non-coding RNA (ncRNA) is a functional RNA molecule that is transcribed 
from DNA but not translated into protein. ncRNAs function to regulate gene expression at 
the transcriptional and post-transcriptional level. The three major classes of short non-
coding RNAs are microRNAs (miRNAs), short interfering RNAs (siRNAs), and piwi-
interacting RNAs (piRNAs). MicroRNAs (miRNAs) are endogenous 22 nt RNAs that play 
important regulatory roles in animals and plants by targeting mRNAs for cleavage or 
translational repression (Fazli Wahid et al.,2010). Both major groups – miRNAs and 
siRNAs- are shown to play a role in heterochromatin formation, histone modification, DNA 
methylation targeting, and gene silencing (David Bartel et al.,2004). miRNAsplay an 
important role in the maturation, development and regulation of B cells, as well the 
maturation of the antibody response (Danger et al.,2014). Expression of the miR-17-92 
cluster (miR-155 and miR-181a) participates in B cell proliferation and apoptosis. This 
cluster functions by targeting BCL-2-like protein 11 (BIM) transcripts, which belong to a 
family of apoptosis regulators. Expression of another miRNA, miR-34a, blocks B cell 
development, which leads to aberrant antibody responses to foreign antigen (Danger et 
al.,2014; Rao et al., 2010). 
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1.4.4- Epigenetic changes in sepsis 
 
Although prior studies of epigenetic changes in sepsis are limited, there are some 
data to suggest a role for epigenetics in sepsis pathophysiology. For instance, clinical studies 
show CD4+ T cell loss in septic patients accompanied by histone methylation and chromatin 
remodelling in the promoters of the T-bet and GATA-3 genes (Javier Cabrera-Perez et 
al.,2014). This contributes to anergy of the CD4+ T cells, which are crucial players in the 
humoral immune response andare essential for formation of functional CD8+ T cell memory 
(Green et al., 2013; Weinstein et al.,2012).  
As mentioned above, LPS exposure affects histone methylation in a number of 
pro-inflammatory genes including IL-6, IL-8, IL-12 and TNF-α (T.Angrisano et al., 2010; 
Cavaillonet al.,  2006; Biswas et al.,  2009). 
DNA methylation changes may also occur in direct response to the pathogen. The 
tumour suppressor gene, runx3, is methylated in gastric epithelial cells in response to 
Helicobacter pylori infection resulting in its downregulation (Y. Katayama et al.,2009). This 
may play a role in the connection between H.pylori infection and gastric cancer (Y. 
Katayama et al., 2009). 
1.5- Summary 
 
The present project aims to study sepsis, a highly complex disease, in an 
innovative way. We have assembled, for the first time, DNA methylation profiles from 
66septic and 68non-septic intensive care patients. Using these samples, we will adopt a 
bioinformatics approach to identifying DNA methylation signatures associated withsepsis. 
We will also correlate epigenetic changes with important clinical outcomes, such as survival 
and organ failure and will look for markerswith prognostic and diagnostic potential. In this 
way, we hope to clarify the role of DNA methylation in the pathogenesis of sepsis and to 
identify new diagnostic tools that will improve our ability to diagnose and manage septic 
patients. 
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2- Materials and Methods 
2.1- DYNAMICS  
 
 The data used in this study were derived from human DNA samples collected as part 
of the DYNAMICS trial (DNA as a Prognostic Marker in ICU patients study) 
(NCT01355042). DYNAMICS was a multi-center prospective observational clinical trial of 
the prognostic value of cell frees DNA (cfDNA) in sepsis. The aim of this proposal is to 
analyze DNA methylation patternsvalidate the prognostic utility of cell free DNA (cfDNA) in 
critically ill septic and non-septic patientsand to use this data to establish two different 
epigenetic signatures that correlate with the septic state as well as with severe disease and 
mortality.  
 The DYNAMICS cohort comprises 1000 patients (400 septic patients and 600 non-
septic critically ill patients) enrolled at 9hospital sites in Canada (Hamilton General Hospital; 
St. Joseph’s Hospital, Hamilton; Ottawa Civic Hospital; and Ottawa General Hospital. Four 
of these hospital sites collected whole blood samples, resulting in a total of 481 available 
DNA samples. For the purposes of the DNA methylation analysis a cohort of 72 septic and 69 
non-septic critically ill patients was selected from the patients enrolled in DYNAMICS.Four 
groups of patients were specifically created: 
1. Septic patients with low severity of illness (MODS ≤ 8) – 34 patients 
2. Septic patients with high severity of illness (MODS ≥ 9) – 32 patients 
3. Non-septic patients with high MODS (≥ 9) at ICU admission – 32 patients 
4. Non-septic patients with low MODS (< 9) at ICU admission – 36 patients 
 
 Groups were balanced in terms of male-female ratio and age. Relevant clinical 
parameters such as survival, presence of septic shock, days to ICU discharge, days to hospital 
discharge, and the presence of co-morbidities (including liver disease, diabetes, chronic heart 
failure, ischemic heart failure, chronic lung disease, AIDS, cancer, chronic renal 
insufficiency, and chronic dialysis) were also recordedfrom the DYNAMICS database. 
Details of the patient’s treatment plan were also available including the presence or absence 
of mechanical ventilation, vasopressors, and steroids and the results of any positive cultures. 
 
On Day 1 of ICU admission, a whole blood sample was collected from each enrolled 
patient. Depending on the hospital site, the sample was collected in either a DNA PaxGene 
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tube or in a tube containing anti-coagulant and then centrifuged to obtain a buffy coat. DNA 
extraction was performed using the DNA QiaQuick kit (Qiagen) andthe samples were 
subjected to bisulfite conversion using the EZ-96 DNA Methylation Kit (Zymo Research, 
Irvine, CA), according to the manufacturer’s specifications. DNA methylation analysis was 
performed by hybridization to the Illumina HumanMethylation 450k beadchip at The Centre 
for Applie Genomics in Toronto, Canada. 
2.2- Data Extraction and Normalization  
 
 The power calculation was based on a case-control design comparing septic patients 
(N=64) and non-septic critically ill patients (N=64).  The log transformed DNA methylation 
level measure (beta value) was assumed to benormally distributed and the Bonferroni-
corrected significance level was set at0.05.  It was assumed thatapproximately 400K of the 
450K CpG probes would pass quality control for the final analysis. A two tail T-test was used 
to evaluate the power given the available sample sizes under different effect sizes. The sample 
size was selected to achieve 80% power given an effect size equal to or larger than 1.15.  
 Data cleaning and normalization was performed by our collaborators in Canada. In 
brief, the ChAMP analysis pipeline, which integrates a number of Bioconductor packages, 
loaded raw data (IDAT files) and performed quality control, normalization, and batch 
correction as described below. Patient samples were excluded if 1) > 20% of sample probes 
had detection p-value > 0.01 or 2) median bisulfite conversion efficiency (BSCE) control 
probe signal < 4000 in the green channel. Seven patient samples were removed. A total of 134 
high quality patient samples were included in the final analysis. Probes with the following 
criteria were excluded: 1) detection p-value < 0.01 in at least 10% of samples, 2) probes 
mapping to sex chromosomes, 3) probes with non-unique genomic mapping (cross-reactive 
probes), and 4) probes containing single nucleotide polymorphism (SNP)-introduced artifacts. 
A total of 414,826 probes passed quality control and were used for further analysis. 
 Three replicate samples from the same patient were processed on 3 separate batches. 
Correlation between replicates was 0.998 after batch correction. White blood cell-type 
proportions were estimated from the methylation data using the reference-based model 
proposed by Housemanusing the function champ.refbase.      
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2.3- Phase 1: Literature Search 
 
 Sepsis is a complex disease and many proteins are involved in its pathogenesis. To 
identify genes associated with sepsis we conducted an extensive literature search. Our focus 
was on identifying proteins involved in 5 key sepsis pathways – namely coagulopathy, 
apoptosis, immune activation, immunosuppression and endothelial dysfunction. Relevant 
citations were identified in Pubmed using the key word “sepsis” in combination with one of 
these pathways. In-depth review of papers published in the most recent 5 years resulted in a 
set of target genes. The genes of interest were subsequently converted to a set of CpG sites 
using the Illumina documentation provided with the HumanMethylation 450k BeadChip 
array. 
  
2.4- Phase 2: Methylation Arrays 
  
 The methylation data obtained from the 450k arrays is represented as beta values. 
These values estimate the site-specific methylation level using the ratio between methylated 
and unmethylated alleles. β values therefore range from 0 and 1, with 0 being unmethylated 
and 1 fully methylated.  
 From the genome-wide data we extracted the beta-values for our CpG sites of 
interest from each of our 134patients. We averaged the beta values across the septic and non-
septic groups and then used the T-test correction for multiple comparison testing, using 
Bonferroni comparisons to determine which CpG sites were significantly differentially-
methylated. To identify the most significant methylation changes we then applied a Δbeta 
value cut-off of 0.02 (Δβ≥ 0.02) as very small methylation differences are unlikely to be of 
biological significance.  
2.5- Characterization of the differentially-methylated CpG sits 
 
  Annotation of individual CpG sites is available from Illumina including gene 
location (1st exon, gene body, 5'UTR or 3'UTR, TSS1500, TSS200) and CpG Island location 
(open sea, S-shore, S-shelf, N-shore, N-shelf, island).  
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2.6- Phase 3: Transcriptomic data analysis 
 
Three datasets relevant to sepsis were identified and analyzed. These include: 
1. Hector Wong - pediatric sepsis (GSE26440) 
2. Mihali Natea- neonatal sepsis (GSE4273) 
3. Brian Scicluna and Tom Van der Poll- pneumonia versus noninfectious 
respiratory failure (GSE74224) 
 
 Analysis of expression data was performed in GEO2R by allocating the patients as 
either septic or non-septic and then using the built-in R script to identify differentially-
expressed genes. We also imposed a minimum expression change ratio of 1.5 fold. This ratio 
was chosen as it suggests biological significance.  
 
2.7- Phase 4: Correlating DNA methylation changes with clinical 
parameters  
  
 Clinical data including survival, length of ICU and hospital stay, culture results, use 
of vasopressors, mechanical ventilation and steroids, was available for our cohort. Clinical 
criteria were used to divide septic patients into groups, which were then compared to 
methylation status at specific CpG sites. Correlations were assessed using a two tailed T-test 
with adjustment for multiple comparison testing, using FDR.  
 
2.8- Statistical analysis 
  
 Statistical analyses wereperformed using the GraphPad Prism 5.0 software. Since the 
methylation values were normalized we were able to perform unpaired t-tests to determine 
statistical significance.  
 Correction for multiple comparisons was performed via adjusted p-values using the 
Bonferroni and FDR. Both these methods attempt to control the expected proportion of false 
discoveries. These corrections are based in an adjustment made to P- values when several 
dependent or independent statistical tests are being performed simultaneously on a single data 
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set. Do to these comparisons the p-value must be divide by the number of comparisons being 
made.  
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2.9- Study pipeline 
 
 
 
 
 
 
 
 
 
 
  
 
Gene selection (literature): Genes 
related with sepsis and different 
metabolic consequences, including 
coagulopathy, apoptosis, immune 
activation, immunosuppression and 
endothelial dysfunction
128 genes 
Pipeline: ≥0.2 and p-value <0.05 61 genes and 595 probes
Gene selection (datasets): GEO 
datasets from Hector Wong, Mihali 
Natea,  Scicluna and Tom Van der Poll.
Pipeline: 1.5 fold-ratio and p-
value<0.05
28 genes
10 genes that are differentially 
methylated and expressed (HLA-A, 
HLA-C, HLA-DOB, HLA-DQB1, ITGB2, 
VARS2, NLRP12, C3AR1, APOL3, FADD)
Correlation between methylation 
levels and clinical features
Septic shock, days to ICU discharge, 
days to hospital discharge, core 
temperature, liver disease, diabetes, 
chronic heart failure, ischemic heart 
failure, chronic lung disease, AIDS, 
cancer and the cancer type, chronic 
renal insufficiency, chronic dialysis.
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3- Results 
3.1- EPSIS Study 
 
 The current study is a nested case-control study of DNA methylation changes in 
sepsis. It utilizes genomic DNA samples obtained from a subset of patients in the 
DYNAMICS (DNA as a Prognostic Marker in ICU patients (clinicaltrials.gov ID 
NCT01355042) cohort to investigatethe importance of epigenetic regulation in the 
pathogenesis, progression, treatment response and outcomes of critically ill septic patients. 
 DYNAMICS was an observational multi-site study of critically patients in Canada 
for which 1000 ICU patients were enrolled, of whom 400 had severe sepsis and 600 had non-
septic critical illness. Four of the nine sites involved in DYNAMICS (Hamilton General 
Hospital; St. Joseph’s Hospital, Hamilton; Ottawa Civic Hospital; and Ottawa General 
Hospital) also consented patients for whole blood DNA samples drawn on day 1 of study 
enrolment. A total of 260 septic and 221 non-septic patients consented to provide whole blood 
samples. 
 For the present study, a total of 141 patient samples from DYNAMICS were 
selected for genomic DNA methylation analysis. Samples were selected to provide equal 
numbers of patients in 4 distinct groups based on sepsis status and severity of illness, as 
indicated by the Multi Organ Dysfunction Score (MODS): 
 
Group 1: Septic patients with high MODS (≥ 9) at ICU admission – 32 patients 
Group 2: Septic patients with low MODS (< 9) at ICU admission – 34 patients 
Group 3: Non-septic patients with high MODS (≥ 9) at ICU admission – 32 patients 
Group 4: Non-septic patients with low MODS (< 9) at ICU admission – 36 patients 
 
 Genomic DNA was extracted by our collaborators in Toronto and bisulfite-
converted (see methods). Hybridization to the Infinium HumanMethylation450 BeadChip 
array, comprising over 450,000 individual CpG sites, was performed at The Centre for 
Applied Genomics in Toronto, Canada. The Human Methylation450 array interrogates 
methylation at >485,000 CpG sites, providing coverage to >99% of RefSeq genes, targeted 
across gene regions including the promoter, 5’UTR, first exon, gene body, and 3’UTR 
(Sandoval et al., 2011). 
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Bisulfite-converted gDNA (500 ng) was hybridized to Infinium Human 
Methylation 450K (HM450K) BeadChips (Illumina, San Diego, CA) and scanned with iScan 
(Illumina) in accordance with manufacturer’s protocol. From the initial cohort of 141 patients, 
only 134 high quality patient samples were included in the final analysis (samples were 
excluded if >20% of sample probes had detection p-value >0.01 or median bisulfite 
conversion efficiency (BSCE) control probe signal <4000 in the green channel).A total of 
414,826 probes passed quality control and were used for further analysis. 
Inclusion Criteria for Sepsis: Patient must have A or B 
and C 
 
Inclusion Criteria for Non-Sepsis: Patient must have A or B or 
C 
 
A. Severe Sepsis 
1.  3 SIRS criteria (systemic 
inflammatory response syndrome) 
2. Infection (suspected or confirmed) 
3.  1 acute organ dysfunction 
 
A.  
1.   Multiple trauma with episode of shock 
on presentation 
2. Patient expected to remain in ICU for  
72 hours 
 
B. Septic Shock 
1. All of the above in “A” and currently 
on vasopressors 
 
B.  
1. Critically Ill Severe Sepsis 
2.  three SIRS criteria (systemic inflammatory 
response syndrome) 
3. Infection (suspected or confirmed) 
4.  1 acute organ dysfunction 
 
C. Patient expected to remain in ICU for  72 
hours 
 
C.  
i.e.: - Intracranial hemorrhage, subarachnoid 
hemorrhage, subdural hemorrhage 
       - No shock 
       - No organ failure 
 
2.  Patient expected to remain in ICU for  72 hours 
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C. 1.   Non-Septic Shock  
  i.e.: - Cardiogenic shock 
                               - Heat shock 
                               - Burns 
                               - Hypovolemia 
  - Pulmonary embolism 
  - Abdominal aortic aneurysm rupture 
  
2.   Patient expected to remain in ICU for  72 hours 
 
Patient data collection for DYNAMICS study 
 
A.  Demographic data 
1. Baseline  
- Date of birth; gender, height and weight 
- Admission diagnosis; admission type – medical vs surgical 
- Severity of illness measurement: APACHE II 
2. Presence of SIRS criteria 
- Fever/hypothermia, tachycardia, tachypnea, leukocytosis/leucopenia 
3. Presence of organ dysfunction at the time of enrolment 
- Cardiac – systolic blood pressure 
- Respiratory – PaO2/FiO2 ratio 
- Renal – creatinine 
- Hematological – platelet 
4. Chronic health variables 
 
B.  Daily data 
1. Interventions and therapies – dialysis, central lines, arterial lines, pulmonary artery catheters, intra aortic balloon 
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pumps, mechanical ventilation, insulin, therapeutic anticoagulation, therapeutic steroids, inotropes 
2. Specimen acquisition for cell free DNA 
3. New sepsis (suspected or confirmed) 
4. Laboratory results relevant to sepsis (white blood cell count, lactate, P/F ratio etc) 
5. ICU specific scoring systems: MODS and SOFA 
6. Vital signs – including temperature, blood pressure, respiratory rate 
7. Fluid status – quantity of fluid intake and output 
 
 
C.  Sepsis specific data 
1. Allmicrobiology culture data – including organisms, and sites of specimen 
All antimicrobials (antibiotics, antifungals, antivirals) agents administered 
 
I r 
 The goal of the current study is to identify sepsis-related genes that are both 
epigenetically modified AND regulated in sepsis. Our collaborators in Canada have 
undertaken an epigenome-wide association study (EPSIS) looking for DNA methylation 
changes that correlate with the presence of sepsis anywhere in the genome. The disadvantage 
of this approach is that with a highly heterogeneous patient population and a large number of 
candidate CpG sites it may miss DNA methylation changes that are biologically relevant to 
sepsis.  The objective of our study is therefore to look at a subset of genes that we believe to 
be important in the pathophysiology of sepsis. By limiting our analysis to this small group of 
genes we hoped to minimizefalse positives and maximize the chances of identifying 
methylation changes that are important for the pathogenesis and prognosis of sepsis.  
3.2- Phase 1: Literature Search 
 
 The first step in our pipeline was to perform an extensive bibliographic investigation 
of the metabolic pathways and genes involved in the pathophysiology of sepsis. As such, 
dozens of articles and journals were read in order to understand which proteins are implicated 
in the pathogenesis and progression of this heterogeneous disease and its systemic effects. 
Table 1: Inclusion and exclusion criteria for the DYNAMICS study and patient data collection summary.  
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Five specific pathways were identified as central to the pathogenesis of sepsis: 
immunoactivation, immunosuppression, coagulopathy, apoptosis and endothelial dysfunction. 
 Our literature review resulted in a list of 128 genes that were highly relevant to the 
pathogenesis and systemic effects of sepsis (table 3).  Genes are divided into 12 groups based 
on their association with the 5 pathways described above. 
 Genes relevant to immunoactivation include those involved in innate immunity, 
adaptive immunity, and inflammation. The innate immune system consists of cells and 
proteins that are always active and ready to mobilize and fight microbes at the site of 
infection. The main components of the innate immune system are 1) physical epithelial 
barriers, 2) phagocytic leukocytes, 3) dendritic cells, 4) natural killer (NK) cells, and 5) 
circulating plasma proteins (Alberts et al., 2002). Genes involved in this pathway include 
TLR-2, TLR-4, TLR-6, TLR-10, CX3AR1, DEFB1, YKL-40. The toll-like receptor genes 
(TLR) are important mediators of innate immunity because they recognize bacterial antigens 
on entry into the body (Kawai et al., 2010). CX3AR1, DEFB1, and YKL-40 are also 
important toinnate immunity because they are associated with neutrophil activity and 
inducing apoptosis. 
 Adaptive immunity is called into action against pathogens that are able to evade or 
overcome the innate immune defense measures. Machinery of the adaptive immune system 
are normally silent; however, when stimulus occurs and is activated, this machinery have the 
capacity to “adapt” to the presence of infectious agents by activating, proliferating, and 
creating potent mechanisms for neutralizing or eliminating the microbes. There are two types 
of adaptive immune responses: humoral immunity, mediated by antibodies produced by B 
lymphocytes, and cell-mediated immunity, mediated by T lymphocytes (Alberts et al., 2002). 
Genes important for the adaptive immune response include CHN2, CD4, CCL-4, BTN3A2, 
C9ORF95, RFX1, C21ORF56, C6ORF15, BATF, CD14, CD40, CD80, CD86, C-SMAC 
[CD2, CD4, CD8, CD28], P-SMAC [ICAM-1, ICAM-2], and D-SMAC. The supramolecular 
activation cluster, or immune synapse, is formed by the P-SMAC, D-SMAC, and C-SMAC 
proteins in response to the tight apposition of a T cell with an antigen-presenting cell (APC) 
(Balbino Alarco´n et al., 2011). At the centre of the immune synapse is the MHC complex, 
which presents the antigen to the T cell. MHC class I proteins are found on the surface of all 
nucleated cells and comprise the HLA-A, HLA-B, and HLA-C proteins while MCH class II 
proteins are found only on dedicated antigen presenting cells (eg dendritic cells, phagocytes) 
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and comprise the HLA-DP, HLA-DM, HLA-DOA, HLA-DOB, HLA-DR, HLA-DQB1, and 
HLA-DQ proteins (Sung Yoon Choo et al., 2017).  
 Another crucial featureof the innate and adaptive immune responses is the release of 
humoral mediators, namely cytokines and chemokines, which modulate the immune response. 
Cytokines play a crucial role in the pathogenesis of sepsis. They are secreted proteins with 
many effects including promoting cell proliferation, cell differentiation, and cell activation. 
These proteins also control immune cell trafficking and the cellular arrangement of immune 
organs. Chemokines have the “power” to decide whether an immune response develops and 
subsequently whether that response is cytotoxic, humoral, cell-mediated, or allergic. 
Chemokine receptor antagonism may represent a novel therapeutic approach against sepsis in 
the future (Raina Davi Ramnath et al., 2006;Borreli et al., 1996). 
 Pro-inflammatory cytokines such as TNF-ɑ and IL-6 contribute to the immune 
response through the promotion and stimulation of the inflammatory response. These pro-
inflammatory mediators facilitate inflammation and trigger pathological pain (Jun-Ming 
Zhang et al., 2007). IL-6 has been shown to play a central role in the neuronal reaction and is 
also involved in microglial and astrocytic activation in the central nervous system (MA Klein 
et al., 1997). TNF-ɑ acts in several different signaling pathways, as well as apoptotic 
pathways, NF-kB activates inflammation as well as stress-activated protein kinases (SAPKs) 
(by NCBI). 
 Heat shock proteins are a crucial and highly conserved family of proteins across 
species. They act as chaperones for the folding and unfolding of proteins. They also play a 
role in cell-cycle control and signaling, and the protection of cells against stress/apoptosis (Li 
Z et al.,2004). During periods of stress, such as sepsis, there is overproduction of heat shock 
proteins. These molecular chaperones act to ensure that proteins are properly folded under 
periods of stress and elevated temperature. They include Hsp40, Hsp60, Hsp70 (Li Z et al., 
2004).  
 
 Although sepsis is commonly associated with overwhelming inflammation, it is also 
accompanied by systemic immunosupression. The signs of immunosuppression in patients 
with sepsis include apoptosis-induced loss of cells of the innate and adaptive immune system 
including CD4+ and CD8+ T cells, B cells, and dendritic cells (Richard Hotchkiss et al., 
2009)and a reduction in the expression of MHC-II complex on macrophages and APCs 
(James Faix et al., 2013).  CARS or immune-paralysis, as it was originally described, is 
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mediated by a predominance of a Th2 T cell response, increased T regulatory cells, apoptosis 
of lymphocytes and decreased MHC class II molecules on monocytes and macrophages (Opal 
et al., 2011). It is accompanied by overexpression of anti-inflammatory cytokines, such as IL-
4 and IL-10 (Jiang et al., 2006.  
 
 Humoral mediators such as IL-4 and IL-10, play an important role in 
immunosuppression by inhibiting TNF-ɑ, thereby augmenting acute-phase reactants and 
immunoglobulins and inhibiting T-lymphocyte and macrocyte functions (Evan et al., 1996). 
 
 Apoptosis, or programmed cell death, is one of the factors that contributes to sepsis 
being such a heterogeneous, aggressive and dysregulated syndrome. “Apoptosis is an 
evolutionarily conserved, energy-dependent mode of cell death requiring the initiation and 
regulation of complex genetic programs” (Mahidhara et al., 2000). Apoptosis has been linked 
to MODS. Septic patients with MODS have elevated levels of soluble Fas (sFas), an 
important apoptosis mediator, which decreases when MODS improves (S Endo et al., 1996). 
The nuclear matrix protein (NMP), a marker of cell death, has also been shown to correlate 
with MODS-scores and disease severity in sepsis (Y Yamada et al., 1998). Additional 
proteins including BIRC1, BIRC2, ML-IAP (anti-apoptotic proteins), BID, BAX, BCL-2, 
FADD, and caspases (pro-apoptotic proteins) are all critical to apoptosis. Cells have the 
capacity for remarkable regeneration in response to injury or trauma. This is also true of 
sepsis-related organ injury, although there is an imbalance between anabolism and catabolism 
that leads to cellular wasting (Rocheteau et al., 2015).  
 The final sepsis-related pathway that was explored was coagulopathy. A large 
number of proteins are involved in regulating coagulation as both pro- and anti-coagulants.  
These include platelet and coagulation proteins (FGA, FGB, FGG, PF4, Heparin, vWF, 
thrombin, thrombomodulin, collagen, tissue plasminogen activator, platelets antithrombin, 
protein C and S, plasminogen) as well as the coagulation factors [II (prothrombin), V, VII, 
VIII, IX, X, XI, XII, XIII, IV]) and proteins related to the complement system (C1q, C1r, 
C1s, C4b, C4aC2b, C2a, C3b, C3a). The complement system is a key player in the defense 
against infections. It comprises a group of plasma membrane and circulating proteins that 
opsonize pathogens and promote their phagocytosis. [REF] 
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 Sepsis has profound effects on coagulation, ranging from mild alterations up to 
severe disseminated intravascular coagulation (DIC) (Paola Saracco et al., 2013). DIC is 
characterized by widespread microvascular thrombosis, which contributes to multiple organ 
dysfunction/failure, and subsequent consumption of platelets and coagulation factors, 
eventually causing simultaneous bleeding and clotting (Cheng-MingTsaoet al., 2015). “The 
pathogenesis of coagulopathy in sepsis is driven by an up-regulation of procoagulant 
mechanisms and simultaneous down-regulation of natural anticoagulants” (Simmons et al., 
2017). 
128 genes across the different pathways involved in sepsis 
Innate immunity TLR-2, TLR-4 TLR-6, TLR-10, 
CX3CR1, DEFB1, YKL-40  
Adaptive immunity  CHN2, CD4+, CCL-4, BTN3A2, 
C9ORF95, RFX1, C21ORF56, C6ORF15, 
BATF, CD5, CD14, CD40, CD80, CD86, 
C-SMAC (CD2, CD4, CD8, CD28), P-
SMAC (ICAM-1 and ICAM-2), D-SMAC  
Proinflammatory pathway NF-KB, TNF-α, IL-1, IL-12, IL-6, IL-8, 
IL-1β, IL-18, IL1R2, MyD88, RAGE, 
HMGB1, NOD-1, Alpha- 1B 
glycoprotein, Haptoglobin, Dipeptidyl 
peptidase-4 
Cell replication and proliferation GSTM3C, BET, INO80, HAS-2, 
WBSCR27, SRNX1, RPGRIP1, C3AR1, 
CEACAM1, SESN-2, HSPG2, A2AP, 
MTCH1 
Membrane proteins Lipocalin (transporter), Lysosome-
associated membrane proteins-1, GNA12, 
OCLN, CLDN1 
Protein folding HSP100, HSP90, HSP70, HSP60 
Anti-apoptotic proteins BIRC1, BIRC2, BIRC5, BIRC6, BIRC8, 
Livin, ML-IAP 
Pro-apoptotic proteins Bid, Bax, Cytochrome C, Apaf-1, Bcl-2, 
Diva, Bok-L, BoK-s, FADD, SMAC, 
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Caspase (1, 2,3,7,8,9, 10, 14)  
Complement system C1q, C1r, C1s, C4b, C4a, C2b, C2a, C3b, 
C3a 
MHC-I proteins HLA-A, HLA-B, HLA-C 
MHC-II proteins HLA-DP, HLA-DM, HLA-DOA, HLA-
DOB, HLA-DQ, HLA-DR, HLA-DPB1 
Platelet and coagulation proteins Fibrinogen (FGA, FGB, FGG), Platelet 
factor 4 (PF4), Factor Xa, Thrombin, 
Heparin, Thrombomodulin, Collagen, 
Tissue plasminogen activator, Platelets 
Antithrombin, Platelet activating factor, 
Protein C and S, Clotting factor, 
Plasminogen,   
Prothrombin Fibrinogen, Vwf, Factor II  
Factor (XI, V, VII, XII, VIII, IX, XIII, 
XIV, X), HMWK  
 
 
3.3- Phase 2: Methylation Arrays 
 
 The EPSIS methylation dataset is, to our knowledge, the first database of genome-
wide DNA methylation data from critically-ill patients and from septic patients of any kind. 
The current study utilizes the EPSIS dataset to perform a targeted analysis of DNA 
methylation changes in sepsis-related genes.  
In Phase 2 of our pipeline we used the EPSIS dataset to look for sepsis-associated DNA 
methylation changes in the 128 genes identified in our literature search. Using the 
documentation provided by the manufacturer, we identified a total of 705 CpG sites located in 
our target genes that are also present in the llumina HumanBeadchip 450k array.  
We next analyzed the EPSIS database to identify which of these 702 CpG sites showed 
significant methylation differences between the septic and non-septic critically-ill patients. 
Using a beta-value difference cutoff of > 2% and a false discovery rate of 5%, we identified a 
total of 595 CpG sites that were differentially methylated in the EPSIS samples. The beta-
Table 2: Reorganization of the 128 genes according to the metabolic pathway in which they are inserted and 
according to their function. 
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value difference cutoff was selected to ensure biological relevance as values below 2% are 
unlikely to be important regulators of gene expression (Pan Du et al., 2010).  
 Initially, we hoped to pair our EPSIS data with an additional database of non-critically 
ill patients as a “negative” control. Our plan was to compare the DNA methylation status of 
our septic and non-septic critically ill patients with that of “healthy” patients. Unfortunately, 
we were unable to locate an appropriate comparison group and realized that we would be 
unable to control adequately for batch effects between the EPSIS samples and any external 
database.  
 
3.4- Heatmap analysis 
 
 To provide a visual representation of the methylation analysis data we constructed 
heatmaps displaying the beta-value difference and p-value of our CpG sites. Two examples 
are shown in Figures 1 and 2. CpG sites indicated in red are hypermethylated in the septic 
samples relative to the non-septic samples, while those shown in blue are hypomethylated. 
The location on the Y axis indicates the p-value, with those located closest to the bottom of 
the heatmap having the smallest p-value, and therefore the greatest statistical (but not 
necessarily biological) significance. As is apparent from the heatmaps, a large percentage of 
CpG sites were significantly differentially methylated between septic and non-septic patients. 
Certain genes including IL-10, NFKB1 and NFKB2 (Figure 1), as well as NLRP2, VARS2 
and ITBG2 (Figure 2) showed a high number of differentially-methylated CpG sites with 
similar direction of methylation change. Other genes, including HMGB1 (Figure 1) and HLA-
DRB1 and HLA-DQB2 showed almost no changes in methylation status.  The TNF gene was 
unique in showing a large number of methylation changes with a mixture of hyper- and hypo-
methylated sites.  
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Figure 1: Heatmap analyzing the differences in the methylation state between a specific cluster of genes, between patients with and without sepsis. 
In the Y axis it indicates the p-value and in the axis of the X the different genes and CpG associated sites. In this heatmap the following cluster of 
genes is analyzed: CLL4, CD14, NFKB1, NFKB2, HMGB1, IL10, IL6, IL8 and TNF-ɑ 
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 Of the 128 genes identified in our literature search, a total of 61 genes contained at 
least 1 differentially-methylated CpG in our methylation analysis. Table 3 shows the list of 61 
genes along with their “average” methylation status.  
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Table 3: Scheme that analyzes the methylation differences among the 61 genes. In the first column the identity of the gene is 
shown; In the second column it analyzes the number of CpG methylated sites on the total number of probes for each gene. In 
the third column the state of change of methylation in each gene is presented; red, hypermethylated genes, blue 
hypomethylated genes and the purple genes with an intermediate state of methylation 
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3.5- CpG Localization 
 
 We next analyzed of the localition of the differentially-methylated CpG sites relative 
to our genes of interest. The Illumina HumanBeadchip 450k array documentation provides 
basic information about CpG localization. Sites are identified as being in one of 6 locations: 
TSS1500, TSS200, 5'UTR, 1st exon, Body, and 3'UTR. The schematic below illustrates these 
locations relative to the gene structure (Figure 3). 
 
TSS1500: from -200 to -1,500 nt upstream of the transcription start site (TSS) 
TSS200: from -200 nt upstream to the TSS itself 
5´UTR: downstream of the TSS and upstream of the initiation codon 
1st exon: the first part of the coding sequence prior to the 1st intron 
Gene body: from the 1st intron to the translation termination codon (TTC) 
3´UTR: between the TTC and the polyadenylation site 
Adapted from: K Look et al., 2014 
Figure 3: Graph showing the number of CpG sites that are hypermethylated (n=380) and hypomethylated (n=214) within 61 genes 
 
Figure 4: Localization of CpG sites along the structure of a gene, including TSS1500, TSS200, 5'UTR, 1st exon, gene body and 
3'UTR 
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 The distribution of CpG sites within genes is important in determining their effect 
on gene regulation. Hypermethylation of CpG sites in the gene promoter is associated with 
inhibition of gene expression while hypermethylation of CpG sites in the gene body is 
associated with increased gene expression (Shimrat Mamrut et al., 2013). Thus, a CpG site 
that is hypermethylated in the promoter will likely have a different impact on transcription of 
the associated gene than a CpG site that is hypermethylated in the 3'UTR. 
.  
 We first analyzed all of our differentially methylated CpG sites to determine their 
localization relative to the associated genes. Figure 5 reveals that 73,5% of the differentially-
methylated sites are located upstream of the transcription start site or in the 5’UTR and 1st 
exon. This compares to 73% amongst the 702 CpG sites that we analysed.  
 
 
 
 
 
Figure 5: Graph analyzing the distribution of the 595 and 702 significant CpG sites across the gene. 
 
 We next divided our differentially-methylated probes according to their methylation 
status – hyper and hypomethylated. We then plotted these two groups of probes individually 
to determine whether there were any differences in their relative localization. Figure 5 shows 
that the hypomethylated probes were much more likely to be localized in the TSS200 or 
5’UTR regions – key gene regulatory regions. As mentioned above, hypomethylation of 
upstream regulatory sequences is usually associated with increased gene expression.  
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Figure 6: Graph analyzing the overall distribution of the hypermethylated and hypomethylated significant probes across the 
gene 
 
  
 We next analysed the location of our CpG sites relative to CpG islands. CpG islands 
are short interspersed DNA sequences. These regions are GC-rich, CpG-rich, and 
predominantly nonmethylated. CpG islands are commonly known as sites of transcription 
initiation, including thousands that are remote from currently annotated promoters (Aimée M. 
Deaton et al., 2011).   Using the documentation from the manufacturer our CpG sites were 
classified as being in the CpG island itself (“island”), within 2kb of a CpG island (“shore”), 
within 2-4kb of a CpG island (“shelf”), or at least 4kb away from a CpG island (“open sea.”). 
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Figure 7: Graph that analyzes the general distribution of the hypermethylated and hypomethylated probes according to the 
CpG islands. 
 
 
 Almost all of the differentially-methylated probes were located within 4kb of a CpG 
island. Interestingly, hypermethylated sites were found primarily on the CpG island and CpG 
shore while hypomethylated sites were found predominantly on the CpG shelf, up to 4kb from 
the CpG island. The presence of hypermethylated CpG sites in the CpG islands is an 
important mechanism for gene inactivation. Other immunosuppressive diseases, such as AIDS 
and lymphoma, also show hypermethylation of the CpG islands (Cheah et al., 1984) whereas 
in normal tissue the majority of CpG islands are completely unmethylated (Bird et al., 1986).  
 
 
 
 
 
 
 
 
 
 
34 
3.6- Phase 3: Transcriptomic data analysis 
 
Epigenetic changes are most relevant when they impact gene regulation. Thus, 
epigenetics is fundamentally the study of gene expression. Although the EPSIS database does 
not include information on gene expression we were able to identify three datasets in the 
Gene Expression Omnibus (GEO) that contained both septic and non-septic patients and that 
we felt were reasonable comparators for the EPSIS data. 
The transcription data sets were as follows: 
 GSE26440 [REF] is a dataset from Hector Wong and co-workers comparing pediatric 
septic vs. non-septic ICU patients. Hector Wong has published several articles (Hector 
Wong et al., 2012: “Genetics and genomics in pediatric septic shock”; “The pediatric 
sepsis biomarker risk model”) on the subject of the intrinsic heterogeneity of clinical 
septic shock; 
 GSE4273 is a dataset contributed by Mihali Natea comprising neonatal sepsis patients. 
Early-onset sepsis remains a common and serious problem for neonates, especially 
preterm infants (Kari A. Simonsen et al., 2014). 
 GSE74224 is a dataset contributed by Brian Scicluna and Tom van der Poll 
comprising adult critically-ill patients with pneumonia versus noninfectious 
respiratory failure. Sepsis and septic shock can result from an infection anywhere in 
the body, including pneumonia. Furthermore, pneumococcus remains the most 
common cause of community-acquired pneumonia worldwide (Tom van der Poll et 
al., 2009). 
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Table 4: Table that summarizes the characteristics of the different GeoDatasets analyzed for the differences in the level of 
gene expression. In the first column it is observed the identity of each dataset and the respective author; in the second column 
the number of patients that compose each of the cohorts and in the third column a succinct explanation of the type of 
comparisons that were performed. 
 
 Although these transcriptomic datasets are not a perfect match for our EPSIS cohort, 
they all contain a mixture of septic and non-septic critically-ill patients. By using 3 different 
databases we hoped to maximize the chances of identifying genes that are differentially-
expressed in sepsis.  
 Genes were considered differentially-expressed in sepsis if they showed a 1.5 fold 
change in expression and an adjusted p-value <0.05 in any of the 3 datasets.  
  
  
 
 
 
Geo Dataset Cohort  
GSE26440-  Hector Wong N=130 Analysis of whole blood 
from children (up to 10 
years old) within 24hrs of 
PICU admission for septic 
shock. 
GSE4273 -  Mihali Natea N=65 Biomarkers have shown 
great promise in diagnosis 
of sepsis and guiding 
appropriate treatment of 
neonates. 
GSE74224 -  Brian 
Scicluna and Tom van der 
Poll 
N=105  Molecular classifier based 
on a small number of 
RNAs expressed in 
peripheral blood 
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 Of the 61 genes identified in phase 2, a total of 10 genes showed differential 
expression in the GEO datasets (figure 8).  
 
 
 
 
 
 
Figure 8: List of 10 genes that after analysis of the methylation data and the analysis of the different datasets of the 
transcriptomics, were presented as differentially methylated and expressed between patients with and without sepsis. 
 
 These 10 genes are both differentially methylated and differentially expressed in 
sepsis. They include 4 members of the human leukocyte antigen genes, which form the class 
II major histocompatibility complex or MHCII. These are HLA-DQB1, and HLA-DOB. 
MHC class II molecules are critical for the initiation of the antigen-specific immune response 
(Holling et al., 2004). Two of the 10 proteins, FADD and APOL3, are involved in apoptosis. 
Apoptosis represents the execution of an ATP-dependent death program that is triggered 
following death receptor activation (Sundar et al.,  2017). FADD is relevant in sepsis because 
it recruits and activates caspase-8 and thereby the downstream executioner caspases 6 and 7 
(Hotchkiss et al., 2009). APOL3 is a member of the apolipoprotein L gene family, a group of 
proteins that can initiate apoptosis, or programmed cell death, by responding to stimuli such 
as DNA damage and cell detachment [Smith and Malik, Genome Res, 2009]. It may play a 
role in sepsis due to its involvement in the neutrophil apoptotic program (Akl et al., 2015).  
 NLRP12 is a cytoplasmic sensor thought to be a negative regulator of inflammation 
(Gurung et al., 2015). It has been proposed as a positive regulator of MHC-I molecule 
expression (Marcela Hernandez et al.,2013) but is a crucial negative regulator of the NF-κB 
signaling pathway (Gurung et al., 2015). 
 The ITGB2 gene belongs to a group of integrins, integral cell-surface proteins that 
participate in cell adhesion as well as cell-surface mediated signaling (by Gene Cards- 
ITGB2). It is important for endothelial integrity (Wilson ZS et al., 2017). 
 HLA-A 
 HLA-C 
 HLA-DQB1 
 HLA-DOB 
 ITGB2 
 FADD 
 NLRP12 
 APOL3 
 VARS2 
 C3AR1 
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 Finally, the VARS2 gene is involved in mitochondrial metabolism. Mutations in this 
gene cause combined oxidative phosphorylation deficiency (Diodato et al., 2014). 
Mitochondrial metabolism is impaired in sepsis leading to relative depletion of cellular energy 
levels (Daria Diodato et al., 2014). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5 shows the direction of methylation and expression change for each of the 10 genes identified in Phase 3. Three of the 
genes are hypomethylated and downregulated – all of these are members of the HLA family. Two genes are hypomethylated 
and upregulated. Two are hypermethylated and upregulated and three genes are hypermethylated and downregulated.  
 
 
 
 
 
 
 
 
 
 
 
 
Gene ID CpG sites Methylation change Transcriptional 
change 
HLA-A 5 Hypomethylated Downregulated 
HLA-C 22 Hypomethylated Downregulated 
HLA-DOB 19 Hypermethylated Downregulated 
HLA-DQB1 22 Hypomethylated Downregulated 
NLRP12 3 Hypermethylated Upregulated 
ITGB2 13 Hypomethylated Upregulated 
C3AR1 3 Hypomethylated Upregulated 
FADD 13 Hypermethylated Upregulated 
APOL3 11 Hypermethylated Downregulated 
VARS2 21 Hypermethylated Downregulated 
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 HLA-A (Downregulated) 
 
 HLA-C (Downregulated) 
 
 HLA-DOB(Downregulated) 
 
 HLA-DQB1 (Downregulated) 
 
 
 
 
 
 
 
 
 
 
39 
 
 NLRP12 (Upregulated) 
 
 
 
 ITGB2 (Upregulated) 
 
 
 
 C3AR1 (Upregulated) 
 
 
 FADD (Upregulated) 
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 APOL3 (Downregulated) 
 
 VARS2 (Downregulated) 
 
Figure 10: Multiple schemes that show the 10 individual genes along with the location of the differentially-methylated CpG 
sites. All of the genes contain at least 3 differentially-methylated sites, suggesting the existence of a differentially-methylated 
region (DMR). No correlation is apparent between the location and direction of methylation change and the direction of 
expression change.  
 
 The last group of analyzes made on these 10 differentially methylated and 
differentially expressed genes was analyzed between the CpG sites, which were significant 
(Fig. 9), their location along the gene and their methylation state, when sepsis occurs. It 
should be noted that, at the very least, there are 3 CpG sites that presented themselves as 
differentially methylated. The different schemes, in figure 10, visually show these methylated 
probes (hypomethylated probes in blue and hypermethylated probes are shown in red). 
The location of these probes was analyzed using data provided by Illumina when performing 
methylation arrays with 450k of probes. Unfortunately, as can be seen in three gene 
situations, namely HLA-C, HLA-DOB and APOL3, it was not possible to present all the 
significant probes. As can be seen from the different schemes, most of the CpG sites are 
located in TSS200 or in the body of the gene. When most probes are located in the TSS200, 
the genes are usually upregulated, whereas genes that are downregulated, most of the CpG 
sites are distributed by the other regions of the gene, specifically the body of the gene. Other 
analyzes would have to be made to draw a direct correlation between the location of the 
probes, their methylation status and the change in direction of expression. However, these 
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schemes show for the first time the relationship between methylation and the expression of 
these genes in sepsis 
 Amongst the non-HLA genes presented in Figure 10, FADD, VARS2, and ITGB2 
are notable for the very large number of differentially-methylated CpG sites. There is also 
some clustering of methylation sites, such as in VARS2 where the hypomethylated sites are 
all located upstream and the hypermethylated sites are all located downstream.  
 
3.7- Phase 4: Correlating DNA methylation changes with clinical 
parameters  
  
 The EPSIS dataset includes clinical data relating to bacterial culture results, the 
presence or absence of septic shock, the use of mechanical ventilation, vasopressors and 
steroids, as well as the presence of pre-existing chronic diseases including cancer and 
ischemic heart failure.  
 In Phase 4 we used the 133 differentially-methylated CpG sites located in the 10 
genes identified in Phase 3 to explore whether any of these sites provided diagnostic or 
prognostic information for our patients. We compared different parameters such as presence / 
absence of septic shock, mechanical ventilation, vasopressors, use of steroids, culture results 
(gram-positive vs gram-negative bacteria), and overall survival (less than 7 days s more than 
two weeks) as the dependent variable for the analysis. 
 We then divided the septic group of patients (n=66) into two groups based on each 
of these criteria and used a T-test and adjusted p-value to determine if there were any 
associations between methylation status at these CpG sites and clinical outcomes.  
 We first compared methylation profiles in septic patients with survival of less than 7 
days (early mortality, n=28) vs those with survival of at least 15 days or longer (early 
survivors, n=14). The results for two CpG sites with differential methylation are shown in 
Figure 11. Site cg22993154 in the HLA-C gene showed a wide range of methylation values 
amongst the early mortality group compared to consistently low methylation levels amongst 
early survivors. This was also true of cg23463743 in HLA-DQB1. A total of 39 CpG sites 
showed differential methylation between the early mortality and early survival groups.  
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Figure 11: Graphs that analyze which gees and associated CpG sites relate survival (patients who survived 7 days less and 
patients who survived longer than 2 weeks) among the group of patients with sepsis (n = 64). Genes presented were A) HLA-
C with CpG site 22993154; B) C3AR1 with CpG site 27423177 and C) HLA-DQB1 with CpG site 23464743 
 
 Type of culture (gram-negative / gram-positive bacteria) 
 
 Only a subset of septic patients had positive cultures available for analysis. Using 
only the septic patients with positive culture results from within 3 days of admission we 
subdivided them into those with gram-positive infections (n=30) and those with gram-
negative infections (n=30). Two sites in the VARS2 gene (cg14935711, cg12457901) 
correlated with the presence of gram positive vs gram negative sepsis. In both cases the CpG 
sites wre relatively hypomethylated amongst patients with gram-positive sepsis. Amongst 
septic patients generally, VARS2 is relatively hypomethylated and downregulated, suggesting 
that this effect is more pronounced in gram-positive infections. Differentially-methylated 
CpG sites were also identified in APOL3 and HLA-DQB1. In total, 55 CpG sites were 
differentially methylated between patients with gram-positive and gram-negative sepsis.  
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Figure 12: Graphs that analyze which genes and CpG associated sites relate the type of bacterial infection (patients who 
were infected by gram-negative bacteria and patients who were infected by gram-positive bacteria) among the group of 
patients with sepsis (n = 64) . Genes presented were A) VARS2 with CpG site14935711; B) VARS2 with CpG site12457901; 
C) APOL3 with CpG site 10257263; D) HLA-DQB1 with CpG site 23464743 
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 Presence/absence of septic shock 
 Septic shock is clinical defined by persisting hypotension requiring vasopressors to 
maintain a mean arterial pressure (Mervyn Singer et al., 2016). Is also known as a subset of 
sepsis with significantly increased mortality due to severe abnormalities of circulation and/or 
cellular metabolism. On average, about 30 to 40% of people with septic shock die (Paul M. 
Maggio). A total of 65 CpG sites were found to be differentially methylated in cases of septic 
shock.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Graphs that analyze which genes and associated CpG sites relate the presence or absence of septic shock among 
the group of patients with sepsis (n = 64). Genes presented were A) APOL3 with CpG site10257263;  
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 Vasopressors  
Septic shock is a severe form of sepsis in which blood pressure is no longer 
maintained due to loss of endothelial integrity and sepsis-induced cardiac dysfunction. 
Vasopressors are medications used to reverse sepsis-induced hypotension (RC Bone et al., 
1992). They have the potential to increase the systemic arterial pressure and to augment 
cardiac contractility (Leeanne Strattonet al., 2017). The septic patient cohort was subdivided 
into those who did and did not require vasopressors on admission to the ICU.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: Graphs that analyze which genes and 
associated CpG sites relate the presence or absence of 
administration of vasopressors among the group of 
patients with sepsis (n = 64). Genes presented were A) 
IL6 with CpG site 05265849; B) HLA-C with CpG site 
23366493 
 
 Mechanical ventilation 
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 Only two of the septic patients were not mechanically ventilated. The sample size 
was therefore insufficient to provide any meaningful data.  
 
 
 Steroids  
 Corticosteroids are often used as a treatment of septic shock although the evidence is 
controversial. Three main indications for linked exist for corticosteroids in sepsis: 1) as 
immunosuppressants; 2) to treat relative glucocorticoid deficiency during critical illness and 
3) for patients who are unresponsive to high-dose vasopressors (PE Marik et al., 2008). Our 
sepsis cohort contained a sub-group of patients who were treated with corticosteroids at the 
discretion of the admitting physician.  
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Figure 15: Graphs that analyze which genes and CpG associated sites relate the presence or absence of steroids 
administration among the group of patients with sepsis (n = 64). Genes presented were A) HLA-DQB1 with CpG site 
22984282; B) HLA-C with CpG site 17250082;  
 
 
 In these last analyzes was made, for the first time for our knowledge, direct relations 
between clinical parameters and the 10 genes differentially methylated and differentially 
expressed in sepsis. Different genes and CpG sites showed crucial for this relationship. Some 
of them deserve attention. 
 HLA haplotypes are one of the genetic features that most strongly associate with 
autoimmunity (Cho et al., 2011). HLA-C is one of the MHC-I proteins, who plays a role as a 
ligand for killer immunoglobulin receptors expressed on NK cells (Maria Eve Blais et al., 
2011). The three main CpG sites (CpG22993154, CpG23366493 and CpG17250082) were 
found to be important in different parameters, thus constituting a good future marker of 
diagnosis in sepsis. On the other hand, HLA-DQB1 plays a central role in the immune system 
by presenting peptides derived from extracellular proteins (U.S National Library of 
Medicine). Associated with this gene are also different probes, CpG23464743 and 
CpG22984282. 
 
 
 
 
 
 
49 
4- DISCUSSION 
 Sepsis is the result of a massive immune response to bacterial infection that gets into 
the blood. A disease that is not heterogeneous and aggressive, such as this one, has taken a 
special emphasis over the years, mainly due to the total lack of knowledge of its 
pathophysiology, as well as the exorbitant expenses to keep these patients in intensive care 
units. The present project aimed to understand the changes in transcriptome and methylome of 
septic and non-septic patients, in order to distinguish and establish two distinct epigenetic 
assemblages. For such, bibliographic reviews of genes important for sepsis, analysis of 
methylation differences, in the first cohort of septic patients done; study of transcript 
differences in transcriptomic datasets previously made and the final ratio of differentially 
methylated and expressed genes with different clinical parameters. 
 
4.1- Phase 1: Literature screen  
 
 The starting point of our study was an intensive bibliographic investigation of the 
metabolic pathways and genes involved in the pathophysiology of sepsis. Five specific 
pathways were identified as being of critical importance: immunoactivation, 
immunosuppression, coagulopathy, apoptosis and endothelial dysfunction. After researching 
and reading dozens of articles on this subject a list of 128 genes was generated, all of which 
are highly relevant to the pathogenesis and consequences of sepsis.  
 These 128 genes fall into a number of functional categories: innate immunity, 
adaptive immunity, proinflammatory mediators, pro- and anti-apoptotic proteins, cell 
replication and proliferation proteins, membrane proteins, protein chaperones, complement 
proteins, MHC-I and MCH-II proteins, and platelet and coagulation proteins.  
 Genes involved in immunoactivation, either as part of the innate or adaptive immune 
systems included the toll-like receptor genes, the MHC-I and MCH-II class proteins, and the 
supramolecular activation cluster genes (P-SMAC, D-SMAC, and C-SMAC).  Genes 
involved in immunosuppression included IL-10, TGF- or IL1B. Apoptosis proteins included 
BIRC1, BID, BAX, and BCL-2. Genes involved in coagulopathy included FGB, FGG, HP or 
vWF. Finally, genes involved in inflammation included NF-KB, TNF-ɑ, RAGE or HMGB1.   
  
 Although this is not an exhaustive list of all the proteins involved in the 
pathogenesis of sepsis, it includes many of the most important players. Our objective was not 
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to itemize every possible protein involved in sepsis. Instead our goal was to generate a list of 
proteins to serve as the basis for a “focused” analysis of DNA methylation in sepsis.  
 This bibliographic review has become essential, as the basis of this whole project. 
 
4.2- Phase 2: Methylation arrays 
 
 Our study is a nested case-control study utilizing genomic DNA samples from the 
DYNAMICS cohort of critically-ill septic and non-septic patients. DYNAMICS was an 
observational multi-site study of 1000 ICU critically patients in Canada (400 septic and 600 
non-septic critical illness patients). From DYNAMICS, 141 patient samples were selected for 
hybridization to the Infinium HumanMethylation450 BeadChip arrays. This represents the 
first cohort of septic patients with genome-wide DNA methylation data, as well as the first 
cohort of critically ill patients. We refer to this cohort as the EPSIS (Epigenetic Profiling in 
Severe Sepsis) cohort.  
 Using the 128 genes identified in phase 1 of our study we identified 705 CpG sites 
contained within these genes and also assayed in the HumanMethylation450 Beadchip Array. 
We then analysed the DNA methylation data to identify which of these CpG sites showed a 
significant difference between septic and non-septic patients.  Using a beta-value difference 
cutoff of > 2% and a false discovery rate of 5%, we identified a total of 595 CpG sites that 
were differentially methylated. These CpG sites represented 61 of our original 128 gene list, 
or approximately 48% of our target genes. When looking at “average” methylation status of 
these genes we found 64% were hypermethylated while 36% were hypomethylated.  
 In parallel to our study, our collaborator Dr. Chris Walsh has been using the same 
genomic methylation data to perform an epigenome-wide association study (EWAS). This 
unbiased approach entails analyzing all of the CpG sites on the beadchip for DNA 
methylation differences associated with sepsis. The EWAS approach has the advantage of 
interrogating all of the available CpG sites in the genome but the disadvantage of identifying 
many false positives as well as many differences that may not be relevant to the pathogenesis 
of sepsis. Our “focused” approach has the benefit of focusing on a smaller number of genes 
and therefore having greater sensitivity for small DNA methylation changes. It also ensures 
that the DNA methylation changes we find are likely to be biologically relevant to sepsis. 
However we may miss important DNA methylation changes in genes that are not as strongly 
associated with sepsis in the current literature. 
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 After we had induced a filter for the beta values (≥.02)  and by calculating the p-
value<0.05, we had arrived at a list of 61 genes. In this list of 61 genes analyzed within all of 
the probes that appeared in the methylation arrays, we counted which CpG sites were 
differentially methylated. And thus understand the average change in methylation for each of 
these genes. In a total of 595 probes, about 64% were hypermethylated (n = 380), while 34% 
of these CpG sites (n = 215) were hypomethylated. These results are important to understand, 
for the first time, the type of alterations, at the level of the methylome that the sepsis patients 
suffer. 
 We next analyzed the localization of the differentially methylated CpG sites relative 
to their associated genes and relative to the CpG islands. The Illumina HumanBeadchip 450k 
array documentation provides basic information about gene localization (TSS1500, TSS200, 
5'UTR, 1st exon, Body, and 3'UTR). Hypermethylation of CpG sites in the gene promoter is 
often associated with inhibition of gene expression while hypermethylation of CpG sites in 
the gene body is associated with increased gene expression.  
 When we analyzed the distribution of these probes from the 61 genes (595 CpG 
sites) and the probes from the initial 128 genes (702 CpG sites), it shows that the distribution 
of these probes accompanies a similar distribution. 
About 25% of all of 595 probes are found in the gene body, while while the highest 
percentage of the 702 probes are in the TSS200. Similarly, 3'UTR is the site in the gene that 
receives the least number of significant probes. Regarding the methylation status of these 
probes, more than 40% of all CpG sites are hypermethylated in the body of the gene, rather 
than about 35% of these are hypomethylated in the 5'UTR. Regarding the methylation status 
of these probes, more than 40% of all CpG sites are hypermethylated in the body of the gene, 
rather than about 35% of these are hypomethylated in the 5'UTR. 
 CpG islands (CGIs) are short interspersed DNA sequences that are often sites of 
transcription initiation. Hypermethylation of CpG islands located in the promoter regions of 
crucial genes, such as tumor suppressor genes, causes suppression of gene expression. 
Looking at our differentially-methylated CpG sites we first note that 99% our differentially-
methylated probes are located in or adjacent to a CpG island.  Amongst the hypermethylated 
probes, 42% localize to CpG islands, while 29% localize to CpG shore (0-2kb from the CpG 
island) and 29% localize to the shelf (2-4kb from the CpG island). Conversely, amongst 
hypomethylated probes, 60% of the probes localize to the CpG island ”shelf” and only 19% 
and 22% to the CpG island and shore respectively. This represents a significant difference 
between our hypermethylated and hypomethylated probes.  
 
 
 
52 
 
 Hypermethylation of important genes, like oncogenes, tumor suppressor genes or 
involved in cell proliferation and apoptosis, are linked to DNA methylation. And most of all 
DNA methylation changes are located in CpG islands (Rafael Irizarry et al.,2009) like we saw 
on our analysis.  
 As a last step, we compared our results with the results from the EWAS study. In 
this comparison only 2 targets of our 10 differentially methylated and differentially expressed 
genes do not appear in the EWAS results, namely HLA-DOB and HLA-DQB1. These two 
genes participate in adaptive immunity, belonging to class II of the MHC complex. These 
results prove to be quite satisfactory, because although in both studies they adopted opposite 
working guidelines, the same targets appeared in both analyzes. 
These targets thus constitute a cluster of genes important to undergo future validation 
analyzes, in order to create a group of prognostic biomarkers for sepsis. 
 
 
4.3- Phase 3: Transcriptomic data 
 
 One of the goals of our study was to correlate epigenetic and transcriptional changes in 
sepsis for the first time. Although no transcriptional data is available for our cohort we were 
able to identify three publicly-available datasets containing both septic and non-septic 
patients. These include Hector Wong’s cohort pediatric septic vs. non-septic ICU patients 
(Hector Wong et al., 2012); Mihali Natea’s cohort of neonatal septic and non-septic patients 
(Kari A. Simonsen et al., 2014). The last dataset was from Brian Scicluna and Tom van der 
Poll’s cohort of adult critically-ill patients with pneumonia versus noninfectious respiratory 
failure (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74224. Although these 
transcriptomic datasets are not a perfect match for our cohort, they provided us with an 
indication of which genes are differentially expressed in whole blood samples from septic and 
non-septic patients.  
 Of the 61 genes with significant methylation changes identified in phase 2, a total of 
10 genes showed differential expression in at least one of these data sets. These genes 
included: HLA-A, HLA-C, HLA-DOB, HLA-DQB1, FADD, C3AR1, ITGB2, VARS2, 
APOL3, NLRP12. We can group these 10 genes according to their roles in sepsis: the HLA 
proteins, HLA-A and HLA-C belongs to MHC-I complex and HLA-DOB, HLA-DQB1 
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belong to the MHC-II group of proteins, which present antigens on antigen presenting cells; 
ITGB2 is a mediator of adaptive immunity that participate in cell adhesion as well as cell-
surface mediated signalling (Wilson ZS et al., 2017). This protein is involved in the 
endothelial integrity. Lack of ITGB2 leads to low leukocyte extravasation from blood into 
tissues; FADD is a pro-apoptotic protein (Sundar et al. 2017), NLRP12 and C3AR1 are 
associated with inflammation. Regarding the NLRP12 gene, this is implicated in the 
activation of proinflammatory caspases (Gurung et al., 2015). Namely to C3AR1 is an 
important factor in the activation of the complement response cascade; and finally APOL3 
and VARS2 are involved in the regulation of cell proliferation, namely in the movement 
of lipids or allow the binding of lipids to organelles (Diodato et al., 2014). 
With respect to the relationship between DNA methylation and gene expression, we don’t see 
a clear correlation in our 10 genes. There are several possible reasons for this. Firstly, the 
relationship between methylation status and gene expression is not always consistent [REF]. 
Althought promoter methylation may prevent binding of transcription factors leading to 
decreased gene expression, it may also prevent binding of transcriptional inhibitors leading to 
increased gene expression. Secondly, our transcriptomic data comes from unrelated datasets. 
We therefore don’t know whether the gene expression changes seen in these datasets reflect 
our patient population. Finally, there may be some false positives in our data. In the absence 
of another cohort we cannot validate our findings.  
 
4.4- Phase 4: Correlating DNA methylation changes with clinical 
parameters 
 Clinical data for the EPSIS cohort includes bacterial culture results, the presence or 
absence of septic shock, the use of mechanical ventilation, vasopressors and steroids, as well 
as the presence of chronic diseases including cancer and ischemic heart failure. Using the 133 
differentially-methylated CpG sites located in the 10 genes identified in Phase 3 we next 
explored whether any of these sites provided diagnostic or prognostic information for our 
patients. The clinical parameters selected were patients' overall survival (less than 7 days vs 
more than two weeks), presence or absence of septic shock, administration of steroids, 
vasopressors and mechanical ventilation, and bacterial culture results (gram-positive vs gram-
negative bacteria).Using only the patients in the sepsis cohort (n=66) we subdivided the 
patients according to the presence or absence of each criteria and then performed direct 
correlations using a T-test and adjusted p-value calculation, using GraphPad software.  
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In our analysis of patients with “early mortality” (mortality in < 7 days) vs “early survivors” 
(survival > 15 days) we found that CpG site 22993154 in HLA-C was able to distinguish the 
two groups. HLA-C is reported to be important for cell survival, especially hematopoietic 
cells, in addition to its role in antigen presentation in the immune system (Ho VT et al., 2006).  
With respect to gram positive vs gram negative infections, CpG site 23464743 in HLA-DQB1 
was able to distinguish the two culture types. 
When we analysed patients for the presence or absence of septic shock we found that CpG 
site 10257263 in the APOL3 gene strongly correlates with septic shock. Septic shock occurs 
when  cardiac dysfunction, vasodilation, and leakage of fluid out of the bloodstream lead to 
dangerously low blood pressures and poor organ perfusion (Mervyn Singer et al., 2016). 
APOL3 is a positive regulator of NF-kB and may also be involved in apoptosis (B. 
Vanhollebeke et al., 2006).  
 
 
4.5- Strengths and weaknesses of this study  
 
As with any project, there are always aspects that need further discussion and 
critical analysis. The EPSIS cohort is the first cohort of septic and non-septic patients 
with genome-wide DNA methylation data. Although the data is extremely novel, it is 
important to address some specific weaknesses of our study: a) the use of whole blood 
samples; b) the use of Day 1 samples; c) the use of GEO datasets for transcriptomic 
validation and d) the relevance of the correlations between our data and the clinical 
parameters. 
 
a) Whole blood samples: Whole blood is easy to collect but it contains a mixed cell 
population. In our patient cohort approximately 80% of the nucleated blood cells are 
neutrophils while the rest are lymphocytes, monocytes, eosinophils and basophils 
(unpublished data). This reduces the chances that we will detect significant 
methylation changes in our cohort. We also don’t know whether any methylation 
changes we find are occurring in neutrophils or in one of the other cell types. This 
could only be resolved by cell sorting prior to methylation analysis.  
b) Day 1 samples: Genomic DNA was collected on Day 1 of ICU admission. This is very 
early in the patient’s course and we may have missed important DNA methylation 
changes that occur later on in sepsis.  
 
 
 
55 
c) GEO datasets: There is no transcriptomic data available for the EPSIS cohort. We 
therefore used data from unrelated datasets of septic and non-septic patients in GEO. 
This data does not necessarily represent gene expression in our patient cohort.  
d) Correlations with clinical parameters: We have identified a number of DNA 
methylation changes that correlate with important clinical parameters, such as survival 
and gram negative vs gram positive infection. These are candidate biomarkers but will 
need to be validated in a separate cohort.  
 
4.6- Comparison with EWAS study 
 
Our collaborators have used the EPSIS dataset to perform an epigenome-wide 
association study. The approach taken in this study was more directed, namely to focus 
on genes directly involved in sepsis. One disadvantage to our approach is that by focusing 
on specific genes, we may have missed other, less obvious, targets. However, the 
opposite may also have happened. By analysing a relatively small group of genes 
involved in the pathogenesis of sepsis, we have improved the sensitivity of our analysis. 
Thus two of the 10 genes we found that are both differentially methylated and expressed 
in sepsis were not identified in the EWAS analysis.  
 
4.7- Future work 
  
 The most important next step in this project is to create a validation cohort so that 
we can confirm our results. Additionally, we would like to create a cohort with both DNA and 
RNA samples, that would allow us to compare DNA methylation and gene expression in the 
same patients. Furthermore, we would like to confirm that correlations between DNA 
methylation changes and clinical parameters that we have identified. DNA methylation 
changes have great potential as clinical biomarkers – we hope that the creation of a set of 
epigenetic-based biomarkers will provide clinicians with a tool that allows them to better 
diagnose sepsis and help guide their treatment decisions. 
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5- Conclusion 
  
 This project focused on the study of sepsis, a highly complex and heterogeneous 
disease, in an innovative and novel way. We have assembled, for the first time, DNA 
methylation profiles from 66 septic and 68 non-septic intensive care patients and we have 
compared these data with transcriptomic information from 3 cohorts of patients with and 
without sepsis. We adopted a bioinformatics approach to identifying and establish DNA 
methylation signatures of sepsis in a focused set of sepsis-related genes. Ten of these genes - 
HLA-A, HLA-C, HLA-DOB, HLA-DQB1, ITGB2, FADD, APOL3, C3AR1, FADD, VARS2 
and NLRP12, showed significant methylation and transcription changes, suggesting 
epigenetic regulation. Furthermore, we identified correlations between several of the CpG 
sites and clinical parameters including gram-positive vs gram-negative infection, septic shock, 
vasopressors, and early mortality vs early survival.   
 The role of epigenetics in sepsis is only just beginning to be explored. Our group has 
established a collaboration with a group in the United States that has a cohort of septic and 
non-septic intensive care patients with correlated RNA and DNA samples. These samples will 
enable us to further explore the relationship between DNA methylation and gene expression, 
and to validate our initial findings. In this way, we hope to clarify the role of DNA 
methylation in the pathogenesis of sepsis and to identify new diagnostic tools that will 
improve our ability to diagnose and manage septic patients.  
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